Posts Tagged ‘EASL 2026 News’
Predicting PSC with a Multi-Biomarker Model
New multi-biomarker blood test model predicts transplant-free survival with high accuracy in PSC.
Read MoreAcute Cholangitis Survey Update
A global survey reveals how acute cholangitis symptom patterns directly predict recovery times.
Read MoreMay 2026 Research Roundup
Read the latest PSC news, including some insights from the EASL 2026 research conference.
Read MoreInternational Survey Highlights Heavy Burden of Itching and Fatigue on Daily Life with PSC
A multinational study reveals the profound impact of itching and fatigue on quality of life, highlighting the urgent need for better treatments.
Read MoreA pilot study reveals blocking the IL-17 pathway is safe and feasible for primary sclerosing cholangitis
A pilot study reveals blocking the IL-17 pathway is safe and feasible for primary sclerosing cholangitis.
Read MoreRedefining Clinical Care: PSC Support Champions Patient-Centred Approaches at International Roundtable
Martine represented PSC Support at an international roundtable at the EASL Congress, advocating for patient-centred clinical trial design.
Read MoreVolixibat Announcement at EASL Congress 2026
The latest results from the VISTAS trial to reduce itch in PSC.
Read More